نتایج جستجو برای: botulinum toxin type e

تعداد نتایج: 2324853  

Journal: :JAMA otolaryngology-- head & neck surgery 2013
Taner Yilmaz Nilda Süslü Gamze Atay Serdar Özer Riza Önder Günaydin Münir Demir Bajin

IMPORTANCE Contact granuloma is a difficult-to-treat laryngeal disorder associated with vocal abuse, habitual throat clearing, and laryngopharyngeal reflux. It has a high propensity for persistence and recurrence despite many treatment alternatives. OBJECTIVE To present our experience with recurrent contact granuloma treated with microlaryngoscopic excision and botulinum toxin injection. DE...

Journal: :Journal of bacteriology 1957
M GORDON M A FIOCK A YARINSKY J T DUFF

Although type E strains of Clostridium botulinum have been implicated in human botulism since 1936, no studies of the isolation or characterization of the toxin have been reported. Crude toxoids have been prepared by various workers for immunization of animals and preparation of antitoxin. Barron and Reed (1954) presented a systematic study of methods for preparation of crude alum precipitated ...

Journal: :JAMA 2012
Jeffrey L Jackson Akira Kuriyama Yasuaki Hayashino

CONTEXT Botulinum toxin A is US Food and Drug Administration approved for prophylactic treatment for chronic migraines. OBJECTIVE To assess botulinum toxin A for the prophylactic treatment of headaches in adults. DATA SOURCES A search of MEDLINE, EMBASE, bibliographies of published systematic reviews, and the Cochrane trial registries between 1966 and March 15, 2012. Inclusion and exclusion...

Journal: :Journal of bacteriology 1961
J GERWING C E DOLMAN D A ARNOTT

Type E strains of Clostridium botulinum tend to produce toxin of relatively low mouse killing power (administered intraperitoneally) in relation to its high lethality per os for man. The explanation of this peculiarity seems to lie in the phenomenon of "activation," whereby type E toxin, when exposed at an appropriate pH in vitro to certain bacterial enzymes (Dolman, 1953, 1957a; Sakaguchi and ...

2010
Shashi K. Sharma Uma Basavanna Hem D. Shukla

Botulinum neurotoxins (BoNTs) are highly potent poisons produced by seven serotypes of Clostridium botulinum. The mechanism of neurotoxin action is a multistep process which leads to the cleavage of one of three different SNARE proteins essential for synaptic vesicle fusion and transmission of the nerve signals to muscles: synaptobrevin, syntaxin, or SNAP-25. In order to understand the precise ...

Journal: :Infection and immunity 1997
N M Bakry Y Kamata L L Simpson

The binding of iodinated botulinum toxin type B to nerve membranes was studied by using rat and mouse preparations. The toxin was examined both in the single-chain and in the proteolytically processed dichain form, and binding sites both in the spinal cord and in various brain regions were assayed. Rat and mouse brains possessed specific binding sites for botulinum toxin type B. The average Kd ...

Journal: :Clinical Interventions in Aging 2007
Christine M Cheng

Botulinum toxin type A injections are one of the most popular cosmetic procedures for diminishing the appearance of facial lines caused by habitual facial muscle contractions. Although the manufacturer's labeling recommends botulinum toxin only for the treatment of glabellar lines among adults younger than 65 years of age, there is widespread use of the toxin for other cosmetic purposes and for...

2003

Description: BOTOX COSMETIC (Botulinum Toxin Type A) Purified Neurotoxin Complex is a sterile, vacuum-dried purified botulinum toxin type A, produced from fermentation of Hall strain Clostridium botulinum type A grown in a medium containing casein hydrolysate, glucose and yeast extract. It is purified from the culture solution by dialysis and a series of acid precipitations to a complex consist...

Journal: :international journal of preventive medicine 0
majid ghasemi mehri salari fariborz khorvash vahid shaygannejad

background: a variety of techniques for the management of spasticity have been suggested, including positioning, cryotherapy, splinting and casting, biofeedback, electrical stimulation, and medical management by pharmacological agents, botulinum toxin a (bta) is now the pharmacological treatment of choice in focal spasticity. bta by blocking acetylcholine release at neuromuscular junctions acco...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید